Christopher Thomas Giordano - 10 Dec 2025 SCHEDULE 13D Report for TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (TENX)

Filing Manager: Christopher Thomas Giordano
Reporting Manager: Christopher Thomas Giordano
Security: TENAX THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol: TENX
Shares outstanding: 18,453,093 shares
Disclosed Ownership: 1,252,965 shares
Ownership: 6.8%
Form type: SCHEDULE 13D
Filing time: 10 Mar 2026, 18:02:42 UTC
Date of event: 10 Dec 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Christopher Thomas Giordano	6.8%	1,252,965	1,252,965	0	/s/ Christopher Thomas Giordano	President and Chief Executive Officer	0001871714